Are generic formulations of carvedilol of inferior pharmaceutical quality compared with the branded formulation?
- Julian C. Smith*
- , Giorgio Tarocco
- , Fabio Merazzi
- , Urs Salzmann
*Corresponding author for this work
- F. Hoffmann-La Roche AG
- Roche SpA
- Pharma Business
Research output: Contribution to journal › Article › peer-review
14
Link opens in a new tab
Citations
(Scopus)